Apellis Pharmaceuticals, Inc. Financial Ratios — APLS Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-110.62	-177.26	-82.68	-48.68	-66.12	-102.81	-51.1	-81.02	-79.44	-68.26	-23.64	2.28
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.49
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.67
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	90.01	92.19	92.53	85.25	84.93	89.81
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	-84.93	-803.43	-786.32	-129.94	-20.88	5.68
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	-85.27	-805.67	-788.38	-130.39	-21.11	5.52
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	99.1
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	-136.86	-1,120.75	-863.81	-132.76	-25.18	2.4
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	-137.59	-1,121.27	-864.7	-133.29	-25.32	2.23
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	-137.59	-1,121.27	-864.7	-133.29	-25.32	2.23
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.14
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	26	27	157	378	210	113	111	470	474
ST Debt	- -	- -	- -	- -	- -	2	3	4	4	6	6	7	101
LT Debt	- -	- -	- -	- -	26	25	154	374	206	107	104	463	374
Total Debt/EBITDA	- -	- -	- -	- -	-0.52	-0.21	-0.55	-1.77	-0.39	-0.19	-0.22	-2.88	8.32
Net Debt/EBITDA	1.18	1.21	1.79	0.91	2.94	1.17	0.73	0.97	0.84	0.77	0.5	-0.25	-0.19
Total Debt/EBIT	- -	- -	- -	- -	-0.52	-0.21	-0.55	-1.77	-0.39	-0.19	-0.21	-2.85	8.56
Net Debt/EBIT	1.18	1.21	1.79	0.91	2.94	1.17	0.73	0.97	0.84	0.77	0.5	-0.25	-0.2
EBITDA to Interest Expense	- -	- -	- -	- -	-135.47	-50.91	-54.38	-7.11	-40.39	-18.18	-17.42	-4.04	1.29
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-135.47	-50.91	-54.7	-7.29	-40.47	-18.22	-17.45	-4.05	1.28
EBIT to Interest Expense	- -	- -	- -	- -	-135.47	-50.91	-54.5	-7.14	-40.5	-18.23	-17.48	-4.08	1.25
Interest Expense	- -	- -	- -	- -	- -	3	5	30	13	33	30	40	44
Common Equity/Total Assets	-265.94	-172.06	-186.32	-358.17	-81.95	-135.98	-149.38	-96.44	-187.88	-303.71	-359.75	-342.96	-280.21
Long-Term Debt/Equity (%)	- -	- -	- -	- -	17.72	15.77	451.15	182.86	103.75	63.04	53.72	202.6	100.94
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-21.48	-10.16	-36.38	-68.18	-14.25	-4.88	-3.83	-18.05	-14.72
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	14.49	12.47	39.67	38.94	23.37	14.09	13.25	52.32	34.75
Total Debt/Equity (%)	- -	- -	- -	- -	17.72	16.8	458.77	184.66	105.82	66.35	57.03	205.56	128.15
Total Debt/Capital (%)	- -	- -	- -	- -	-21.48	-10.83	-37	-68.85	-14.53	-5.13	-4.07	-18.31	-18.69
Total Debt/Total Assets (%)	- -	- -	- -	- -	14.49	13.29	40.34	39.32	23.84	14.83	14.06	53.08	44.12
Net Debt to Equity	-105.21	-103.01	-102.94	-104.49	-100.21	-92.7	-611.81	-101.17	-227.1	-270.24	-132.71	18.18	-2.95
Net Debt/Capital (%)	260.71	573.64	120.24	80.04	50	35.03	26.97	18.57	21.62	16.71	8.39	-1.4	0.36
EBITDA	-4	-11	-20	-27	-51	-128	-287	-213	-535	-593	-515	-163	57
EBITDA-CapEx	-4	-11	-20	-27	-51	-128	-289	-218	-536	-595	-516	-164	57
Operating Income (Loss)	-4	-11	-20	-27	-51	-128	-288	-214	-536	-595	-517	-165	55

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	7.03	12.6	11.25	6.83	26.8	10.35	5.35	6.84	5.31	3.29	1.42	2.22	1.44
Current Ratio	7.67	13.17	11.89	7.52	27.77	11.89	5.67	7.15	6.25	4.29	3.1	4.25	3.14
Quick Ratio	7.13	13.03	11.25	6.83	26.8	10.35	5.35	6.84	5.39	3.52	2.33	3.68	2.58
CFO/Avg Current Liab	- -	-11.31	-8.81	-7.6	-9.14	-11.13	-5.1	-1.65	-4.33	-3.43	-2.86	-0.41	0.18
Common Equity/Total Assets	-265.94	-172.06	-186.32	-358.17	-81.95	-135.98	-149.38	-96.44	-187.88	-303.71	-359.75	-342.96	-280.21
Long-Term Debt/Equity (%)	- -	- -	- -	- -	17.72	15.77	451.15	182.86	103.75	63.04	53.72	202.6	100.94
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-21.48	-10.16	-36.38	-68.18	-14.25	-4.88	-3.83	-18.05	-14.72
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	14.49	12.47	39.67	38.94	23.37	14.09	13.25	52.32	34.75
Total Debt/Equity (%)	- -	- -	- -	- -	17.72	16.8	458.77	184.66	105.82	66.35	57.03	205.56	128.15
Total Debt/Capital (%)	- -	- -	- -	- -	-21.48	-10.83	-37	-68.85	-14.53	-5.13	-4.07	-18.31	-18.69
Total Debt/Total Assets (%)	- -	- -	- -	- -	14.49	13.29	40.34	39.32	23.84	14.83	14.06	53.08	44.12
CFO/Total Liabilities	-508.85	-919.71	-589.22	-714.58	-140.39	-308.36	-59.47	-21.23	-82.44	-87.02	-100.09	-13.38	6.43
CFO/CapEx	- -	-498.69	- -	- -	- -	- -	-124.71	-29.6	-510.54	-337.1	-769.39	-218.03	144.81
Altman's Z-Score	-5.24	-3.91	-3.25	-7.26	4.53	7.23	-0.37	2.57	-0.11	-0.29	1.27	-0.1	0.65

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	13.18	8.46	3.7	3.32	3.18
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	27.7	43.14	98.55	110.1	114.75
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	0.64	0.11	0.5	1.03	0.91
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	571.58	3,302.87	723.87	353.09	399.79
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	2.98	1.69	2.77	3.18	1.39	3.43
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	122.67	215.63	131.9	114.65	263.17	106.53
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-122.67	383.65	3,214.12	707.78	200.02	408.01
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	-543.88	-3,259.73	-625.32	-243	-285.04
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	16	86	146	81	143
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	6	30	33	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	10	54	83	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	31	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	81	143

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	- -	301	717	1,905	4,299	3,991	5,487	7,104	3,954	3,169
- Cash & Cash Equivalents	5	14	36	25	176	176	352	566	640	552	351	411	466
+ Preferred Equity and Hybrid Capital	17	36	77	92	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	26	27	157	378	210	113	111	470	474
Enterprise Value	12	22	41	67	152	568	1,710	3,799	3,501	5,048	6,864	4,012	3,177
Total Capital	3	11	6	-6	-123	-250	-424	-549	-1,446	-2,196	-2,727	-2,566	-2,539
Total Debt/Capital (%)	- -	- -	- -	- -	-21.48	-10.83	-37	-68.85	-14.53	-5.13	-4.07	-18.31	-18.69
Total Debt / EV	- -	- -	- -	- -	0.17	0.05	0.09	0.1	0.06	0.02	0.02	0.12	0.15
EV/Sales	- -	- -	- -	- -	- -	- -	- -	15.16	52.6	66.93	17.31	5.13	3.16
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.75
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.32
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.73
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.6
Diluted Market Cap	- -	- -	- -	- -	301	717	1,905	4,299	3,991	5,487	7,104	3,954	3,262
Diluted Enterprise Value	12	22	41	67	152	568	1,710	4,111	3,561	5,048	6,864	4,012	3,270
EV per Share	0.66	1.23	2.28	3.71	10.94	10.45	27.49	50.55	41.47	47.57	57.84	32.38	25.18
TTM Sales	- -	- -	- -	- -	- -	- -	- -	251	67	75	397	781	1,004
TTM EBITDA	-4	-11	-20	-27	-51	-128	-287	-213	-535	-593	-515	-163	57
TTM Operating Income	-4	-11	-20	-27	-51	-128	-288	-214	-536	-595	-517	-165	55
TTM Cash Flow to Firm	-3	-10	-19	-26	-46	-129	-206	-130	-550	-481	-565	-47	86
TTM Free Cash Flow to Firm	-3	-10	-19	-26	-46	-129	-204	-125	-549	-480	-564	-47	87

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	- -	-6.46	-5.47	-9.1	-27.73	-7.1	-10.71	-11.96	-45.21	71.47
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.32
Enterprise Value	12	22	41	67	152	568	1,710	3,799	3,501	5,048	6,864	4,012	3,177
Low Price	- -	- -	- -	- -	12.45	11.45	12.5	16.85	27.5	33.32	19.83	24.34	16.1
EV/Sales	- -	- -	- -	- -	- -	- -	- -	15.16	52.6	66.93	17.31	5.13	3.16
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.75
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	141.54
Price/Earnings Average	- -	- -	- -	- -	-4	-8.16	-4.68	-7.62	-5.5	-8.23	-13.37	-27.42	130.71
Price/Earnings High	- -	- -	- -	- -	-6.57	-13.65	-6.78	-12.65	-8.26	-11.39	-21.27	-46.21	200.42
Price/Earnings Low	- -	- -	- -	- -	-3.39	-4.88	-2.55	-3.67	-3.11	-5.42	-4.45	-15.24	90.72
Price/Book Value	- -	- -	- -	- -	-2.02	-2.59	-3.28	-4.64	-2.41	-2.38	-2.5	-1.3	-1.05
Price/Book Value Average	- -	- -	- -	- -	-1.37	-3.76	-2.45	-2.84	-2.48	-2.32	-2.49	-1.79	-0.97
Price/Book Value High	- -	- -	- -	- -	-2.25	-6.29	-3.55	-4.71	-3.72	-3.22	-3.96	-3.01	-1.49
Price/Book Value Low	- -	- -	- -	- -	-1.16	-2.25	-1.34	-1.37	-1.4	-1.53	-0.83	-0.99	-0.67
Price/Tangible Book Value	- -	- -	- -	- -	2.02	4.46	55.67	21.02	20.09	32.3	36.52	17.3	8.56
Price/Tangible Book Value Average	- -	- -	- -	- -	1.37	6.46	41.66	12.84	20.66	31.59	36.34	23.74	7.91
Price/Tangible Book Value High	- -	- -	- -	- -	2.25	10.81	60.32	21.32	31.02	43.73	57.81	40.01	12.12
Price/Tangible Book Value Low	- -	- -	- -	- -	1.16	3.87	22.73	6.19	11.69	20.81	12.1	13.2	5.49
Price/Sales	- -	- -	- -	- -	- -	- -	- -	17.15	59.96	72.75	17.91	5.06	3.16
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	10.48	61.67	71.15	17.82	6.94	2.92
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	17.4	92.58	98.49	28.35	11.7	4.47
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	5.05	34.88	46.88	5.93	3.86	2.02
Price/Cash Flow	- -	- -	- -	- -	-6.46	-5.47	-9.02	-26.79	-7.09	-10.68	-11.94	-45	69.91
Price/Cash Flow Average	- -	- -	- -	- -	-4.38	-7.93	-6.75	-16.37	-7.29	-10.44	-11.89	-61.76	64.56
Price/Cash Flow High	- -	- -	- -	- -	-7.19	-13.26	-9.78	-27.18	-10.94	-14.46	-18.91	-104.07	98.99
Price/Cash Flow Low	- -	- -	- -	- -	-3.71	-4.75	-3.68	-7.89	-4.12	-6.88	-3.96	-34.32	44.81
Price/Free Cash Flow Average	- -	- -	- -	- -	-4.38	-7.93	-6.81	-16.94	-7.3	-10.48	-11.9	-62.04	66
Price/Free Cash Flow High	- -	- -	- -	- -	-7.19	-13.26	-9.86	-28.13	-10.97	-14.5	-18.93	-104.55	101.2
Price/Free Cash Flow Low	- -	- -	- -	- -	-3.71	-4.75	-3.71	-8.17	-4.13	-6.9	-3.96	-34.48	45.81
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	9.73	55.21	65.32	17.22	7.02	2.92
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	16.65	86.13	92.66	27.75	11.78	4.48
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	4.3	28.42	41.06	5.33	3.93	2.03
EV/EBITDA Average	-2.98	-1.97	-2.05	-2.46	-1.08	-6.97	-4.28	-11.46	-6.87	-8.31	-13.25	-33.61	51.49
EV/EBITDA High	-2.98	-1.97	-2.05	-2.46	-3.66	-12.44	-6.51	-19.61	-10.72	-11.78	-21.35	-56.4	78.88
EV/EBITDA Low	-2.98	-1.97	-2.05	-2.46	-0.46	-3.7	-2.03	-5.07	-3.54	-5.22	-4.1	-18.84	35.78
EV/EBIT Average	-2.98	-1.97	-2.05	-2.46	-1.08	-6.97	-4.27	-11.41	-6.85	-8.29	-13.2	-33.25	52.94
EV/EBIT High	-2.98	-1.97	-2.05	-2.46	-3.66	-12.44	-6.49	-19.53	-10.69	-11.75	-21.28	-55.78	81.1
EV/EBIT Low	-2.98	-1.97	-2.05	-2.46	-0.46	-3.7	-2.02	-5.05	-3.53	-5.21	-4.09	-18.63	36.79
Last Price	- -	- -	- -	- -	21.7	13.19	30.62	57.2	47.28	51.71	59.86	31.91	25.12
High Price	- -	- -	- -	- -	24.17	32	33.18	58.03	73	70	94.75	73.8	35.57
Enterprise Value Average	12	22	41	67	55	891	1,231	2,439	3,675	4,927	6,828	5,485	2,934
Enterprise Value High	12	22	41	67	186	1,591	1,870	4,174	5,733	6,989	11,004	9,203	4,495
Enterprise Value Low	12	22	41	67	23	474	583	1,078	1,892	3,097	2,113	3,074	2,039

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	39	39	39	39	50	56	64	76	98	111	120	124	127
Diluted Weighted Avg Shares	18	18	18	18	14	54	62	75	84	106	119	124	130
Basic Weighted Avg Shares	18	18	18	18	14	54	62	75	84	106	119	124	126
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	3.33	0.79	0.71	3.34	6.31	7.96
EBITDA per Share	-0.22	-0.62	-1.11	-1.51	-3.66	-2.35	-4.62	-2.83	-6.33	-5.59	-4.34	-1.32	0.45
Operating Income per Share	-0.22	-0.62	-1.11	-1.51	-3.66	-2.35	-4.63	-2.84	-6.35	-5.6	-4.36	-1.33	0.44
Basic EPS, GAAP	-0.22	-0.6	-2.57	-1.5	-3.68	-2.34	-4.9	-4.59	-8.84	-6.15	-4.45	-1.6	0.18
Basic EPS from Cont Ops	-0.22	-0.6	-2.57	-1.5	-3.68	-2.34	-4.9	-4.59	-8.84	-6.15	-4.45	-1.6	0.18
Diluted EPS, GAAP	-0.22	-0.6	-2.57	-1.5	-3.68	-2.34	-4.9	-4.59	-8.84	-6.15	-4.45	-1.6	0.17
Diluted EPS from Cont Ops	-0.22	-0.6	-2.57	-1.5	-3.68	-2.34	-4.9	-4.59	-8.84	-6.15	-4.45	-1.6	0.17
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.19	-0.55	-1.04	-1.44	-3.36	-2.41	-3.39	-2.14	-6.67	-4.84	-5.01	-0.71	0.36
Free Cash Flow per Basic Share	-0.19	-0.55	-1.04	-1.44	-3.36	-2.41	-3.42	-2.21	-6.68	-4.86	-5.02	-0.71	0.36
Cash & Equivalents per Share	0.26	0.75	1.99	1.37	12.66	3.24	5.66	11.68	8.3	5.2	2.96	3.32	3.7
Book Value per Share	-0.76	-1.36	-3.93	-5.43	-10.76	-5.09	-9.34	-12.32	-19.62	-21.76	-23.91	-24.5	-23.88
Tangible Book Value per Share	-0.68	-1.25	-2.33	-3.77	10.74	2.96	0.55	2.72	2.35	1.6	1.64	1.84	2.93

Apellis Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)